| 1 |
32291610 | A Translational Physiologically Based Pharmacokinetics/Pharmacodynamics Framework of Target-Mediated Disposition, Target Inhibition and Drug-Drug Interactions of Bortezomib. | 2020 Apr 14 |
1 |
| 2 |
29802543 | Clinical Pharmacokinetics and Pharmacodynamics of Bortezomib. | 2019 Feb |
4 |
| 3 |
27325500 | Bortezomib and ixazomib protect firefly luciferase from degradation and can flaw respective reporter gene assays. | 2016 Sep 15 |
2 |
| 4 |
25915157 | Human bone marrow niche chemoprotection mediated by cytochrome P450 enzymes. | 2015 Jun 20 |
1 |
| 5 |
26622646 | Effect of CYP2C19 and CYP3A4 gene polymorphisms on the efficacy of bortezomib-based regimens in patients with multiple myeloma. | 2015 Aug |
1 |
| 6 |
22087865 | Effect of cytochrome P450 3A4 inducers on the pharmacokinetic, pharmacodynamic and safety profiles of bortezomib in patients with multiple myeloma or non-Hodgkin's lymphoma. | 2011 Dec 1 |
2 |
| 7 |
20575631 | Drug interaction between itraconazole and bortezomib: exacerbation of peripheral neuropathy and thrombocytopenia induced by bortezomib. | 2010 Jul |
4 |
| 8 |
20837660 | Metabolism and action of proteasome inhibitors in primary human hepatocytes. | 2010 Dec |
1 |
| 9 |
20110052 | Effect of the CYP3A inhibitor ketoconazole on the pharmacokinetics and pharmacodynamics of bortezomib in patients with advanced solid tumors: a prospective, multicenter, open-label, randomized, two-way crossover drug-drug interaction study. | 2009 |
3 |
| 10 |
16489083 | Phase I trial of bortezomib in combination with docetaxel in patients with advanced solid tumors. | 2006 Feb 15 |
4 |
| 11 |
16764098 | Bortezomib: new indication. Second-line treatment of myeloma: limited efficacy, major risks. | 2006 Jun |
1 |
| 12 |
15764713 | Human metabolism of the proteasome inhibitor bortezomib: identification of circulating metabolites. | 2005 Jun |
1 |
| 13 |
16103134 | Relative contributions of the five major human cytochromes P450, 1A2, 2C9, 2C19, 2D6, and 3A4, to the hepatic metabolism of the proteasome inhibitor bortezomib. | 2005 Nov |
2 |